Company Profile
Physiomics plc
Company Overview
Physiomics plc (AIM: PYC) at its core is a quantitative pharmacology (modeling and simulation) and data science consultancy supporting the development of new therapeutics. From discovery through to the clinic, we support our clients derive insights from both their R&D and external data sources to enable smarter design and decision making – helping them accelerate and de-risk drug development.
The Company has a high-profile brand and an established customer base of clients in the UK, Europe and North America, ranging from emerging biopharma to top-tier pharma and leading research institutes. We have now completed over 120 projects and have modeled over 125 targets & drugs.
The business is now in a period of growth, with a primary focus around expanding its core modeling and simulation service business, supporting clients across a wider array of therapeutic areas, modalities, and in different geographies. We are also building adjacent / complimentary service lines that leverage our existing capabilities to offer broader integrated solutions to our clients. These new service lines include the recent launch of our Biostatistics services.
www.physiomics.co.uk